MET-independent lung cancer cells evading EGFR kinase inhibitors are therapeutically susceptible to BH3 mimetic agents (Q30502341)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
MET-independent lung cancer cells evading EGFR kinase inhibitors are therapeutically susceptible to BH3 mimetic agents
scientific article

    Statements

    MET-independent lung cancer cells evading EGFR kinase inhibitors are therapeutically susceptible to BH3 mimetic agents (English)
    1 reference
    Weiwen Fan
    1 reference
    Zhe Tang
    1 reference
    Lihong Yin
    1 reference
    Bei Morrison
    1 reference
    Said Hafez-Khayyata
    1 reference
    Pingfu Fu
    1 reference
    Honglian Huang
    1 reference
    Rakesh Bagai
    1 reference
    Shan Jiang
    1 reference
    Adam Kresak
    1 reference
    Scott Howell
    1 reference
    Amit Vasanji
    1 reference
    Chris A Flask
    1 reference
    Balazs Halmos
    1 reference
    Henry Koon
    1 reference
    Patrick C Ma
    1 reference
    9 May 2011
    1 reference
    71
    1 reference
    13
    1 reference
    4494-4505
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit